Wells Fargo & Company »

Fortress Biotech shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Fortress Biotech (FBIO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Fortress Biotech

Tip: Access up to 7 years of quarterly data

All positions including Fortress Biotech held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fortress Biotech by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $35k 18k 2.00
2023-12-31 $1.2k 398 3.02

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Fortress Biotech

Rosalind Advisors
Vanguard Group
Acadian Asset Management
Nantahala Capital Management
Shikiar Asset Management
Pvg Asset Management
Geode Capital Management
GSA Capital Partners
CI Private Wealth
Susquehanna International
Envestnet Asset Management
BlackRock
Commonwealth Equity Services
Wealth Enhancement Advisory Services
Northern Trust

View all funds holding Fortress Biotech